¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"amino acid activating enzyme"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® retinoic acid ÇÑ±Û ·¹Æ¼³ë»ê
¼³¸í   
  C20H28O2. ºñŸ¹Î AÀÇ ¾ËÄڿñ⸦ ¾Ëµ¥È÷µå·Î »êÈ­ÇÑ ÈÄ ´Ù½Ã Ä«¸£º¹½Ç»êÀ¸·Î »êÈ­ÇÏ¿© ¾òÀº »ê. ¹ß»ýÁßÀÇ ¼¼Æ÷¿¡ ÀÛ¿ëÇÏ¿© ÇüŸ¦ ¸¸µå´Âµ¥ °ü¿©ÇÑ´Ù.
¿µ¹® ribonucleic acid ÇÑ±Û ¸®º¸ÇÙ»ê
¼³¸í   
  Ribonucleotide monomer·Î ÀÌ·ç¾îÁø ÇÙ»êÀ¸·Î ¿°±â, ´ç, ÀλêÀ¸·Î ±¸¼ºµÈ´Ù. ¿°±â´Â adenine, guanine, cytosine, uracilÀÇ 4Á¾·ù°¡ ÀÖÀ¸¸ç, ´çÀº 5ź´çÀÌ´Ù. RNA´Â DNA¸¦ ÁÖÇüÀ¸·Î ÇÏ¿© »óº¸ÀûÀ¸·Î °áÇÕ, Çü¼ºµÇ¸ç ´Ü¹éÁúÀ» ¸¸µé¾î³»´Â µ¥¿¡ ÀÖ¾î Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù.
  
  Àü·É RNA(mRNA)´Â ´Ü¹éÁú ÇÕ¼º¿¡ À־¡À報⺻ÀÌ µÇ´Â DNAÀÇ ¼­¿­À» »óº¸ÀûÀ¸·Î ¿Å°Ü ¹Þ¾Æ Àü´ÞÇϴ Àü·É±¸½ÇÀ» Çϴ RNA. ¸®º¸¼Ø RNA(rRNA) ¸®º¸¼ØÀ» Çü¼ºÇϴ 4°¡Áö RNA»ç½½(28S, 18S, 5.8S, 5S·Î ±¸¼º). Àü´Þ RNA(tRNA) Æ¯Á¤ ¾Æ¹Ì³ë»êÀ» ÇÑÂÊ ³¡¿¡ Áö´Ï°í »óº¸Àû ¼­¿­ÀÇ mRNA¿Í ÀϽÃÀû °áÇÕÀ» ÀÌ·ç¸ç ´Ü¹éÁú ÇÕ¼º¿¡ Á÷Á¢ ±â¿©Çϴ RNAÀÌ´Ù.
¿µ¹® acid ÇÑ±Û »ê
¼³¸í   
  ¹°¿¡ ³ì¾ÒÀ» ¶§ ÀÌ¿ÂÈ­ÇÏ¿© ¼ö¼Ò ÀÌ¿ÂÀ» ¸¸µå´Â ¹°Áú. ½Å¸ÀÀÌ ³ª°í Ã»»ö ¸®Æ®¸Ó½º Á¾À̸¦ ºÓ°Ô º¯È­½ÃŰ¸ç ¿°±â¿ÍÀÇ ÁßÈ­ ¹ÝÀÀ¿¡ ÀÇÇÏ¿© ¹°°ú ¿°À» ¸¸µé°í ÀÌ¿ÂÈ­ ¿­¿¡¼­ ¼ö¼Òº¸´Ù ¾Õ¿¡ Àִ ±Ý¼Ó°ú ¹ÝÀÀÇÏ¿© ¿°À» ¸¸µé¸é¼­ ¼ö¼Ò¸¦ ¹ß»ý½ÃŲ´Ù. ¼ö¼Ò ¿øÀÚ¸¦ ÀÌ¿ÂÈ­Çϴ ÈûÀÇ °­¾à¿¡ µû¶ó °­»ê°ú ¾à»êÀ¸·Î ³ª´¶´Ù.
¿µ¹® acetic acid ÇÑ±Û ¾Æ¼¼Æ®»ê, ÃÊ»ê
¼³¸í   
  ºÐÀÚ½ÄÀº C2H4O2, ºÐÀÚ·® 60.05ÀÇ Àú±Þ Áö¹æ»êÀÌ´Ù. CH3COOHÀÇ ±¸Á¶½ÄÀ» °¡Áø ¹«»ö¾×ü·Î 16.7¡É¿¡¼­ ³ì°í 118.0¡É¿¡¼­ ²ú´Â´Ù. ½ÄÃÊÀÇ ½Å¸ÀÀ» ³»´Â °ÍÀ̰í, ³óÃàµÈ °ÍÀ» ºùÃÊ»êÀ̶ó ÇÑ´Ù. »ó¿Â¿¡¼­´Â ¾×üÀ̸砼ö¿ë¾×Àº ¾à»ê¼ºÀÌ´Ù. »ýü³»¿¡¼­´Â ÀϹÝÀûÀ¸·Î ¾Æ¼¼Æ¿ CoA·Î Á¸ÀçÇϸ砾Ƽ¼Æ¿±âÀÇ °ø±Þ¿øÀÌ µÇ´Â ¿Ü¿¡ Áö¹æ»êÀ̳ª ½ºÅ×·ÎÀ̵堵îÀÇ »ý¼ºÀç·á·Î Áß¿äÇÏ´Ù. ¾Æ¼¼Æ¿ CoA·ÎºÎÅʹ ÄÉÅæÃ¼°¡ ÇÕ¼ºµÇ¸ç Á¶Á÷ÀÇ ¿¡³ÊÁö¿øÀÌ µÈ´Ù.
¿µ¹® acetylsalicylic acid ÇÑ±Û ¾Æ¼¼Æ¿»ì¸®½Ç»ê
¼³¸í   
  »óǰ¸íÀÌ ¾Æ½ºÇǸ°(asprin)ÀΠ¾à. ´ëÇ¥ÀûÀΠºñ½ºÅ×·ÎÀ̵å Ç׿°¾àÀÌ´Ù. Áï Ç׿°Áõ(anti-inflammatory), ÁøÅë(analgesis), ÇØ¿­(anti-pyretic)ÀÇ È¿°ú°¡ ¸ðµÎ ¶Ù¾î³ªÁö¸¸ À§ÀåÀå¾Ö, °ú´ÙÈ£Èí, ¶óÀÌÁõÈıº(Reye syndrome) µîÀÇ ºÎÀÛ¿ëÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adaptive enzyme
    ÀûÀÀÈ¿¼Ò
  • allosteric enzyme
    ¾Ë·Î½ºÅ׸®È¿¼Ò
  • blood enzyme level
    Ç÷ÁßÈ¿¼Ò³óµµ
  • brancher enzyme
    °¡ÁöÄ¡±âÈ¿¼Ò, ºÐÁöÈ¿¼Ò
  • branching enzyme
    °¡ÁöÄ¡±âÈ¿¼Ò, ºÐÁöÈ¿¼Ò
  • constitutive enzyme
    ±âº»±¸¼ºÈ¿¼Ò
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • cytosolic enzyme
    ¼¼Æ÷¾×È¿¼Ò
  • debrancher enzyme
    °¡ÁöÁ¦°ÅÈ¿¼Ò, Å»ºÐÁöÈ¿¼Ò
  • digestive enzyme
    ¼ÒÈ­È¿¼Ò
  • double-sandwich enzyme-linked immunosorbent assay
    °ãÈ¿¼Ò¸é¿ªÃøÁ¤(¹ý)
  • extracellular enzyme
    ¼¼Æ÷¿ÜÈ¿¼Ò
  • enzyme
    È¿¼Ò
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
  • enzyme assay
    È¿¼ÒÃøÁ¤
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acid rain
    »ê¼ººñ
  • acid
    Ȑ
  • acetic acid
    ¾Æ¼¼Æ®»ê, ÃÊ»ê
  • acetoacetic acid
    ¾Æ¼¼Å侯¼¼Æ®»ê
  • anti-double stranded deoxyribonucleic acid antib antibody
    Ç×ÀÌÁß°¡´Úµð¿£¿¡ÀÌÇ×ü
  • arachidonic acid
    ¾Æ¶ó۵·»ê
  • arsenic acid
    ºñ»ê
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê
  • calcium ethylenediaminetetraacetic acid
    Ä®½·¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • delta-aminolevulinic acid
    µ¨Å¸¾Æ¹Ì³ë·¹ºÒ¸°»ê
  • deoxyribonucleic acid
    µð¿Á½Ã¸®º¸ÇÙ»ê, µð¿£¿¡ÀÌ
  • folic acid
    Æú»ê, ¿±»ê
  • hippuric acid
    È÷Ǫ¸£»ê, ¸¶´¢»ê
  • hydrochloric acid
    ¿°»ê
  • mandelic acid
    ¸¸µ¨¸°»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • allosteric enzyme
    ¾Ë·Î½ºÅ׸®È¿¼Ò
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • antibody capture enzyme-linked immunosorbent assay
    Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤¹ý
  • autolytic enzyme
    ÀÚ°¡¿ëÇØÈ¿¼Ò
  • double-sandwich enzyme-linked immunosorbent assay
    °ãÈ¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
  • enzyme assay
    È¿¼ÒÃøÁ¤
  • enzyme labeled antibody
    È¿¼ÒÇ¥ÁöÇ×ü
  • enzyme-linked immunosorbent assay
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • blood enzyme level
    Ç÷ÁßÈ¿¼Ò³óµµ
  • branching enzyme
    °¡ÁöÄ¡±âÈ¿¼Ò, ºÐÁöÈ¿¼Ò
  • enzyme-linked immunoelectrotransfer blot
    È¿¼Ò¸é¿ªÀÌÀû¹ý, È¿¼Ò¿¬°ü¸é¿ªÀü±âÀü´ÞÁ¡
  • constitutive enzyme
    ±âº»±¸¼ºÈ¿¼Ò
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • curdling enzyme
    ÀÀÀ¯È¿¼Ò
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • guanosine triphosphate-activating protein
    »ïÀλ걸¾Æ³ë½Å Ȱ¼º´Ü¹éÁú
  • platelet activating factor
    Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
  • platelet-activating factor (PAF)
    Ç÷¼ÒÆÇ Ȱ¼ºÈ­ÀÎÀÚ
  • platelet-activating factor (paf)
    Ç÷¼ÒÆÇȰ¼ºÈ­ÀÎÀÚ(úìá³÷ùüÀàõûùì×í­)
  • Ketogenic amino acids
    ÄÉÅæÃ¼Çü¼º(¡­û¡à÷)¾Æ¹Ì³ë»ê(¡­ß«)
  • amino apheresis machine
    ¾Æ¹Ì³ëºÐ¹Ý¼ú±â±â
  • amino compound
    ¾Æ¹Ì³ëÈ­ÇÕ¹°(¡­ûùùêÚª).
  • amino group
    ¾Æ¹Ì³ë±â(¡­Ðñ).
  • amino sugar
    ¾Æ¹Ì³ë´ç(¡­ÓØ).
  • amino terminal
    ¾Æ¹Ì³ëÁ¾´Ü<¸»´Ü>.
  • renal amino aciduria
    ½Å¼º ¾Æ¹Ì³ë»ê´¢
  • 3,4-dihydroxyphenylacetic acid, homogentisic acid
    3,4-µðÈ÷µå·Ï½ÃÆä´Ò ¾Æ¼¼Æ¾»ê= È£¸ð°Õƾ»ê
  • abietinic acid ; abietic acid
    ¾Æºñ¿¡Æ¾»ê.
  • acetic anhydride-acetic acid-sulfuric acid
    ¹«¼öÃÊ»ê-ÃÊ»ê-Ȳ»ê
  • acid-base balance=acid-base equilibrium
    »ê¿°±â ÆòÇü(¡­øÁû¬)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • metabolic defect of amino acid (alkaptonuria)
    ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
  • nonessential amino acid
    ºñÇʼö¾Æ¹Ì³ë»ê
  • sulfur-containing amino acid
    Ȳ(üÜ)ÇÔÀ¯¾Æ¹Ì³ë»ê
  • catabolite activating protein
    ÀÌÈ­»ê¹° Ȱ¼ºÈ­´Ü¹éÁú
  • conglutinogen activating factor
    ±³Âø¿ø (conglutinogen, factor IÀÇ ¿¾¸»)
  • descending reticular activating system
    ÇÏÇ༺ ¸Á»óȰ¼º°è(ù»ú¼àõ ØÑßÒüÀàõͧ)
  • guanosine triphosphate-activating protein
    »ïÀλ걸¾Æ³ë½Å Ȱ¼º´Ü¹éÁú
  • lymphocyte activating factor
    ¸²ÇÁ±¸È°¼ºÀÎÀÚ
  • lymphocyte activating factor (LAF)
    ¸²ÇÁ±¸ Ȱ¼ºÈ­ÀÎÀÚ
  • lymphocyte-activating determinant
    ¸²ÇÁ±¸È°¼º °áÁ¤±â
  • macrophage activating factor (MAF)
    ´ë½Ä¼¼Æ÷ Ȱ¼ºÀÎÀÚ
  • macrophage chemotactic and activating factor
    ´ë½Ä¼¼Æ÷ ÁÖÈ­ ¹× Ȱ¼º ÀÎÀÚ
  • paf(platelet activating factor)
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ(úìá³÷ù üÀàõì×í­)
  • platelet activating factor
    Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
  • platelet-activating factor (PAF)
    Ç÷¼ÒÆÇ Ȱ¼ºÈ­ÀÎÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amino acid composition
    ¾Æ¹Ì³ë»ê Á¶¼º(ðÚà÷)
  • amino acid incorporation
    ¾Æ¹Ì³ë»ê(ß«) ÆíÀÔ(øºìý)
  • amino acid nitrogen
    ¾Æ¹Ì³ë»ê(ß«) Áú¼Ò(òòáÈ)
  • amino acid oxidase
    ¾Æ¹Ì³ë»ê(ß«) ¿Á½Ãµ¥À̽º
  • amino acid replacement
    ¾Æ¹Ì³ë»ê(ß«) ´ëü(ÓÛôð)
  • amino acid residue
    ¾Æ¹Ì³ë»ê(ß«) Àܱâ(íÑÐñ)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê(ß«) ¼­¿­(ßíæê)
  • amino acid sequencer
    ¾Æ¹Ì³ë»ê(ß«) ¼­¿­°áÁ¤±â(ßíæê̽ïÒÐï)
  • amino acid side chain
    ¾Æ¹Ì³ë»ê(ß«) °ç»ç½½
  • amino acid starvation
    ¾Æ¹Ì³ë»ê(ß«) ±â¾Æ(ÑÆä»)
  • amino acid substitution
    ¾Æ¹Ì³ë»ê ġȯ(öÇüµ)
  • aromatic amino acid
    ¹æÇâÁ·(Û»úÅðé) ¾Æ¹Ì³ë»ê(ß«)
  • basic amino acid
    ¿°±â¼º(ç¤Ðñàõ) ¾Æ¹Ì³ë»ê(ß«)
  • tert-BOC-amino acid
    Å͸£Æ®-BOC-¾Æ¹Ì³ë»ê(ß«)
  • CBZ-amino acid
    (å²) carbobenzoxy-¾Æ¹Ì³ë»ê(ß«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oxalic acid
    ¿Á»ì»ê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê
  • salicylic acid
    »ì¸®½Ç»ê
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
KAF conglutinogen-activating factor; killer-assisting factor; kinase activating factor
LAF laminar air flow; Latin American female; leukocyte-activating factor; lymphocyte-activating factor
PAF paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl...
RAS rapid atrial stimulation; recurrent aphthous stomatitis; reflex activating stimulus; reliability, av...
NAA N-acetyl aspartate; naphthaleneacetic acid; neutral amino acid; neutron activation analysis; neutrop...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AP4 D,L-2-amino-4-phosphonobutyric acid
2-APH 2-Amino-7-phosphonoheptanoic acid
AP7 2-Amino-7-phosphonoheptanoic acid
AP5 2-amino 5-phosphonovaleric acid
AIB 2-amino isobutyric acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vasoactive amino
    Ç÷°ü Ȱ¼º ¾Æ¹Î
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅٽŠÀüȯ È¿¼Ò
  • angiotensin-converting enzyme
    ¾ÈÁö¿ÀÅٽŠÀüȯ È¿¼Ò
  • converting enzyme
    Àüȯ È¿¼Ò
  • digestive enzyme
    ¼ÒÈ­ È¿¼Ò
  • enzyme activator
    È¿¼Ò Ȱ¼ºÁ¦
  • enzyme disorder
    È¿¼Ò Àå¾Ö
  • enzyme immunoassay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
    ¼Ò·®ÀÌ¶óµµ ±× Ȱ¼ºÀ» °ËÃâÇÒ ¼ö ÀÖ´Â °í°¨µµÀÇ È¿¼Ò¸¦ Ç¥½ÃÀÚ·Î Çϰí Ç׿ø ȤÀº Ç×ü, ³ª¾Æ°¡¼­´Â ƯÀÌÀûÀ¸·Î ¹ÝÀÀÇÏ´Â ¹°Áú, lectin, C1q µîÀ» È­ÇÐÀûÀ¸·Î °áÇÕ½ÃÄÑ, Ç׿ø ȤÀº Ç×ü µûÀ§¸¦ ÃøÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • enzyme inhibition
    È¿¼Ò ¾ïÁ¦
  • enzyme labeled antibody
    È¿¼Ò Ç¥Áö Ç×ü
  • enzyme marker study
    È¿¼Ò Ç¥Áö ¿¬±¸
  • enzyme precursor
    È¿¼Ò Àü±¸Ã¼
  • enzyme-labelled antibody
    È¿¼Ò Ç¥Áö Ç×ü
  • enzyme-linked immunoadsorbent assay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
  • enzyme-linked immunosorbent assay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
amino acid isomerases <enzyme> Enzymes that catalyze either the racemization or epimerization of chiral centres within amino acids or derivatives.
Registry number: EC 5.1.1.-
(12 Dec 1998)
amino acid naphthylamidases <enzyme> Registry number: EC 3.4.11.
(12 Dec 1998)
amino acid neurotransmitters Amino acids released by neurons as intercellular messengers. Among the amino acid neurotransmitters are glutamate (glutamic acid) and gaba which are, respectively, the most common excitatory and inhibitory neurotransmitters in the central nervous system.
(12 Dec 1998)
amino acid oxidases Flavoenzymes oxidizing, with O2 and H20, either l-or d-amino acids specifically, to the corresponding 2-keto acids, NH3 and H2O2.
Compare: amino acid dehydrogenases, yellow enzyme.
(05 Mar 2000)
amino acid oxidoreductases <enzyme> A class of enzymes that catalyze oxidation-reduction reactions of amino acids.
Registry number: EC 1.4.
(12 Dec 1998)
amino acid permease <enzyme> A widely distributed group of large Integral membrane proteins, required for the entry of amino acids into cells.
(18 Nov 1997)
amino acid reagent A reagent used in the identification and quantification of amino acids.
(05 Mar 2000)
amino acid receptor <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor.
(18 Nov 1997)
amino acid sequence The sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation.
(12 Dec 1998)
amino acid substitution The naturally occurring or experimentally induced replacement of one or more amino acids in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
(12 Dec 1998)
amino acid transmitter <biochemistry> Amino acids released as neurotransmitter substances from nerve terminals and acting on postsynaptic receptors for example _ aminobutyric acid (GABA) and glycine that are fast inhibitory transmitters in the mammalian central nervous system.
Glutamate and aspartate mediate fast excitatory transmission. Strychnine (for glycine) and bicuculline for GABA) are blocking agents for amino acid action.
(18 Nov 1997)
aromatic d-amino-acid decarboxylase <enzyme> An enzyme that catalyses the decarboxylation of l-dopa to dopamine, of l-tryptophan to tryptamine, and of l-hydroxytryptophan to serotonin; important in the biosynthetic pathway of catecholamines and melanin.
Synonym: dopa decarboxylase, hydroxytryptophan decarboxylase, tryptophan decarboxylase.
(05 Mar 2000)
aromatic-l-amino-acid decarboxylases <enzyme> An enzyme group with broad specificity. The enzymes decarboxylate a range of aromatic amino acids including dopa (dopa decarboxylase), tryptophan, and hydroxytryptophan.
Chemical name: Aromatic-L-amino-acid carboxy-lyase
Registry number: EC 4.1.1.28
(12 Dec 1998)
basic amino acid An amino acid containing a second basic group (usually an amino group); e.g., lysine, arginine, ornithine.
Synonym: dibasic amino acid.
(05 Mar 2000)
receptors, amino acid Cell surface proteins that bind amino acids and trigger changes which influence the behaviour of cells. Glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and gaba and glycine receptors are the most common receptors for fast inhibition.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • aminobenzoic acid
    ¾Æ¹Ì³ë¾È½ÄÇâ»ê
  • arsenious acid
    ¾Æºñ»ê
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê(ºñŸ¹Î cÀÇ º°¸í)
  • barbituric acid
    ¹Ù¸£ºñÅõ¸£»ê
  • butyric acid
    ³«»ê
  • capric acid
    Ä«ÇÁ¸£»ê
  • caproic acid
    Ä«ÇÁ·Î»ê
  • carbolic acid
    ¼®Åº»ê
  • carbonic acid
    ź»ê
  • carbonic acid gas
    ź»ê°¡½º
  • cevitamic acid
    ºñŸ¹Î C
  • chloric acid
    ¿°¼Ò»ê
  • chlorous acid
    ¾Æ¿°¼Ò»ê
  • cyanic acid
    ½Ã¾È»ê
  • deoxyribonucleic acid
    µð¿Á½Ã¸®º¸ ÇÙ»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á